Reactions of para-substituted nitrosobenzenes with human hemoglobin.
Bio-monitoring the covalent binding of nitrosoarenes to the SH groups of human hemoglobin has been proposed as a reliable approach to get an integral parameter for exposure control and possibly risk assessment of persons exposed to aromatic amines and nitro compounds. Availability of nitrosoarenes to bind to the cysteine residues is greatly influenced by the competition of hemoglobin iron with nitrosoarenes. In contrast to earlier reports, we found that nitrosobenzene has a 14 fold higher affinity for "stripped" human hemoglobin than oxygen. The binding mode is similar to gaseous ligands and exhibits the same free energy of cooperation and sensitivity to heterotropic effectors like inositol hexaphosphate. To elucidate the electronic influence of para substituents, 4-chloronitrosobenzene, 4-nitrosotoluene and 4-nitrosophenetole were tested. A linear free energy relationship was found for all equilibrium parameters with a reaction constant rho = 3, when using Hammett sigma p constants. Similarly, the apparent second order rate constants for binding of para-substituted nitrosobenzenes to the cysteine residues (Cys beta 93) in hemoglobin followed the Hammett relationship with lg k-lg k0 = 1.7 X sigma p (r2 = 0.99). In case of 4-chloronitrosobenzene covalent binding proceeded biphasically and a "semimercaptal"-like intermediate was observed. The affinities for hemoglobin iron and for the SH groups were highest with 4-chloronitrosobenzene and lowest with 4-nitrosophenetole. All nitrosobenzenes were capable to produce ferrihemoglobin. In the absence of oxygen, 4-chloronitrosobenzene hemoglobin decayed with formation of ferrihemoglobin. Presumably the nitroxide radical anion is formed as an intermediate which comproportionates into the azoxy derivative. It is assumed that the efficiency of the microscopic compartmentation of nitrosoarenes by binding to hemoglobin iron has important impacts on the toxicokinetics of these compounds.
D003545:Cysteine / Q000378:metabolism; D005914:Globins / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007501:Iron / Q000378:metabolism; D009578:Nitrobenzenes / Q000378:metabolism*; D009603:Nitroso Compounds / Q000378:metabolism; D010108:Oxyhemoglobins / Q000378:metabolism; D010615:Phenacetin / Q000031:analogs & derivatives / Q000378:metabolism; D011485:Protein Binding; D013053:Spectrophotometry; D014050:Toluene / Q000031:analogs & derivatives / Q000378:metabolism
D006454:Hemoglobins; D009578:Nitrobenzenes; D009603:Nitroso Compounds; D010108:Oxyhemoglobins; C037221:4-nitrosophenetole; D014050:Toluene; C027669:4-nitrosotoluene; D005914:Globins; C100003:deoxyhemoglobin; C018484:4-chloronitrosobenzene; D007501:Iron; D010615:Phenacetin; D003545:Cysteine